Tuesday, March 1, 2022

March 01, 2022 at 07:50PM OBIZUR

Product approval information is indicated for the treatment of bleeding episodes in adults with acquired hemophilia A.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eOiasBC
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)